Logo image of COV.PA

COVIVIO (COV.PA) Stock Fundamental Analysis

Europe - EPA:COV - FR0000064578 - REIT

56.5 EUR
-1 (-1.74%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

3

Overall COV gets a fundamental rating of 3 out of 10. We evaluated COV against 40 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COV had positive earnings in the past year.
COV had a positive operating cash flow in the past year.
Of the past 5 years COV 4 years were profitable.
In the past 5 years COV always reported a positive cash flow from operatings.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

With a Return On Assets value of 1.63%, COV perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
With a Return On Equity value of 5.08%, COV perfoms like the industry average, outperforming 52.50% of the companies in the same industry.
COV has a Return On Invested Capital (3.21%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COV is in line with the industry average of 3.43%.
The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

COV has a Profit Margin (30.46%) which is comparable to the rest of the industry.
COV's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 57.81%, COV is doing worse than 67.50% of the companies in the same industry.
In the last couple of years the Operating Margin of COV has remained more or less at the same level.
With a Gross Margin value of 74.42%, COV perfoms like the industry average, outperforming 52.50% of the companies in the same industry.
In the last couple of years the Gross Margin of COV has remained more or less at the same level.
Industry RankSector Rank
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

COV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for COV has been increased compared to 1 year ago.
Compared to 5 years ago, COV has more shares outstanding
The debt/assets ratio for COV has been reduced compared to a year ago.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

COV has an Altman-Z score of 0.54. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.54, COV is doing worse than 72.50% of the companies in the same industry.
The Debt to FCF ratio of COV is 28.44, which is on the high side as it means it would take COV, 28.44 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 28.44, COV is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.07 is on the high side and indicates that COV has dependencies on debt financing.
The Debt to Equity ratio of COV (1.07) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Altman-Z 0.54
ROIC/WACC0.56
WACC5.73%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

COV has a Current Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
COV has a Current ratio of 0.76. This is in the better half of the industry: COV outperforms 65.00% of its industry peers.
COV has a Quick Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
COV has a Quick ratio of 0.69. This is in the better half of the industry: COV outperforms 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.98% over the past year.
The Earnings Per Share has been decreasing by -3.39% on average over the past years.
Looking at the last year, COV shows a very strong growth in Revenue. The Revenue has grown by 27.96%.
Measured over the past years, COV shows a small growth in Revenue. The Revenue has been growing by 1.17% on average per year.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
COV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.04% yearly.
EPS Next Y10.05%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
EPS Next 5YN/A
Revenue Next Year-0.88%
Revenue Next 2Y1.86%
Revenue Next 3Y3.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

COV is valuated correctly with a Price/Earnings ratio of 12.26.
Compared to the rest of the industry, the Price/Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 70.00% of the companies listed in the same industry.
COV is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.97, which indicates a very decent valuation of COV.
60.00% of the companies in the same industry are cheaper than COV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of COV to the average of the S&P500 Index (22.71), we can say COV is valued slightly cheaper.
Industry RankSector Rank
PE 12.26
Fwd PE 11.97
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

COV's Enterprise Value to EBITDA is on the same level as the industry average.
62.50% of the companies in the same industry are cheaper than COV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.03
EV/EBITDA 17.22
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.22
PEG (5Y)N/A
EPS Next 2Y2.75%
EPS Next 3Y2.84%

4

5. Dividend

5.1 Amount

COV has a Yearly Dividend Yield of 6.20%, which is a nice return.
COV's Dividend Yield is a higher than the industry average which is at 5.57.
Compared to an average S&P500 Dividend Yield of 2.38, COV pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.2%

5.2 History

The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

92.95% of the earnings are spent on dividend by COV. This is not a sustainable payout ratio.
DP92.95%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

COVIVIO

EPA:COV (9/16/2025, 7:00:00 PM)

56.5

-1 (-1.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners39.95%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.31B
Analysts81.25
Price Target64.25 (13.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.2%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.95%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.79%
PT rev (3m)6.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 11.97
P/S 4.6
P/FCF 16.03
P/OCF 6.28
P/B 0.77
P/tB 0.8
EV/EBITDA 17.22
EPS(TTM)4.61
EY8.16%
EPS(NY)4.72
Fwd EY8.35%
FCF(TTM)3.52
FCFY6.24%
OCF(TTM)8.99
OCFY15.92%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)1.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
FCFM 28.68%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Debt/EBITDA 9.39
Cap/Depr 417.19%
Cap/Sales 44.51%
Interest Coverage 250
Cash Conversion 106.87%
Profit Quality 94.14%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.54
F-Score7
WACC5.73%
ROIC/WACC0.56
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y10.05%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year-0.88%
Revenue Next 2Y1.86%
Revenue Next 3Y3.04%
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year11.8%
EBIT Next 3Y7.1%
EBIT Next 5Y7.68%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.56%
OCF growth 3Y12.5%
OCF growth 5Y4.86%